Local Anesthesia and Tuberculin Skin Test in Infants and Children - Full Text View

Sponsored by:	Assistance Publique - Hôpitaux de Paris
Information provided by:	Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:	NCT00309673

Purpose

The use of local anaesthesia efficiently reduces pain due to needle puncture. However, when tuberculin skin test is performed it is the skin reaction to tuberculin injection that is studied. It is a quantitative skin reaction measured in millimiters. From the study of literature it is not known whether local anaesthetic modify skin reaction to tuberculin. Therefore, before recommending the use local anaesthesia for tuberculin intradermal injection we have to rule out a potential effect of local anaesthetic on the result of the test. This is particularly important in children, since there are more sensitive to pain than adults

Condition	Intervention
Tuberculosis	Drug: lidocaine / Prilocaine

MedlinePlus related topics: Anesthesia Tuberculosis

Drug Information available for: Tuberculin Purified Protein Derivative Lidocaine Prilocaine Prilocaine hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Single Blind, Active Control, Single Group Assignment, Safety/Efficacy Study
Official Title:	Local Anesthesia Effect on Tuberculin Skin Test Results in Infants and Children

Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:

Measurement of tuberculin skin tests reaction performed with and without
local anaesthesia, in a child (intra subject reproducibility)

Secondary Outcome Measures:

influence of local anaesthesia use, on tuberculin skin test interpretation
between observer reproducibility
pain evaluation in child over 5 years of age between tuberculin skin tests performed with and without local anaesthesia
relationship between local anaesthesia use and failure to perform a correct intradermal injection
local tolerance to lidocaine / prilocaine

Estimated Enrollment:

60

Eligibility

Ages Eligible for Study:	1 Month to 15 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

hospitalized or non hospitalized infant or child (3 months-15 years)requiring a tuberculin skin test, in our hospital. hospitalized 1 to 3 months old infants requiring a tuberculin skin test, in our hospital.

-

Exclusion Criteria:

child with contra indication to the use of Lidocaine / prilocaine
child with evolutive dermatitis on forearms
premature or newborn (less than 1 month of age)
infants (1 - 24 months of age)who has yet received repeated local anaesthesia (at least 2)during the 24 previous hours
infants (1 - 24 months of age)who is treated with a drug that could enhance the risk of methhaemoglobinemia
child with previous evere local reaction to tuberculin injection (necrosis,ulceration)
child with history of tuberculosis disease
child with hepatic failure
parents or the child himself if lod enough, have not given their agreement for the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00309673

Contacts

Contact: Nicole Beydon, MD	+33 140 032 000	nicole.beydon@rdb.aphp.fr
Contact: Estelle Marcault, ARC	+33 140 256 252	estelle.marcault@bch.aphp.fr

Locations

France
Robert Debré Hospital
Paris, France, 75019

Sponsors and Collaborators

Assistance Publique - Hôpitaux de Paris

Investigators

Principal Investigator:

Nicole Beydon, MD

APHP

More Information

No publications provided

Study ID Numbers:	CRC05001
Study First Received:	March 31, 2006
Last Updated:	March 31, 2006
ClinicalTrials.gov Identifier:	NCT00309673
Health Authority:	France: Afssaps - French Health Products Safety Agency

Keywords provided by Assistance Publique - Hôpitaux de Paris:

tuberculosis, tuberculin, childhood, pain

Study placed in the following topic categories:

Bacterial Infections
EMLA
Gram-Positive Bacterial Infections
Prilocaine

Lidocaine
Mycobacterium Infections
Pain
Tuberculosis

Additional relevant MeSH terms:

Anesthetics, Combined
Sensory System Agents
Therapeutic Uses
Physiological Effects of Drugs
Central Nervous System Depressants
Anesthetics

Peripheral Nervous System Agents
Central Nervous System Agents
Pharmacologic Actions
Anesthetics, Local
Actinomycetales Infections

ClinicalTrials.gov processed this record on February 12, 2009